FIND THE RIGHT TREATMENT
Finding the right epilepsy treatment matters for every patient—right now
After their first failed anti-seizure
medication (ASM), patients are
73% MORE LIKELY
to have uncontrolled seizures.1
The likelihood of seizure freedom
DIMINISHES
with each new ASM.1
WHY WAIT? AIM FOR THE POSSIBILITY OF ZERO SEIZURES FROM THE START
Explore a treatment option for partial onset seizures in adults
IMPACT OF EPILEPSY
Just 1 seizure can make a significant impact on a patient’s lifestyle
WHEN SEIZURES REMAIN UNCONTROLLED, PATIENTS ARE1*:
6X
more likely to have depression
4.5X
more likely to be prevented from driving
3X
more likely to experience limitations in employment
2X
more likely to have limits in education
Patients with uncontrolled seizures have an increased risk of SUDEP2†
SUDEP=sudden unexpected death in epilepsy.
HEAR FROM SELIM R. BENBADIS, MD, ON THE NEED FOR THE SUDEP CONVERSATION
The risk of complacency:
Talking to patients about SUDEP
In this video, hear Dr Benbadis speak to the importance of fighting complacency in drug‑resistant patients, and why discussing the risk of SUDEP with patients who continue to face uncontrolled seizures can be a critical conversation to have.
Learn about a treatment option that can provide the possibility of zero seizures
HISTORY OF ANTI-SEIZURE MEDICATIONS (ASMs)
Many patients with epilepsy have a history of being let down
During the past 3 decades, despite new ASMs coming to market, seizure freedom rates have remained nearly the same1,2*
RATES OF ZERO SEIZURES BY DECADE OF APPROVAL FOR A RANGE OF ASMs3†
1990-19994,5
2.1%-8.7%
vs 0%-2.2% with placebo
2000-20096,7
2.2%-7.4%
vs 0.8%-1.2% with placebo
2010-20198-10
2.0%-8.2%
vs 0%-2% with placebo
Prior to the 1990s, there was little information on seizure
freedom rates with ASMs used as add-on therapy—and even
less information about how these rates were determined3
EPILEPSY IS NOT AS CONTROLLED AS YOU MAY THINK
HEAR FROM SELIM R. BENBADIS, MD, ON THE DANGERS OF UNCONTROLLED EPILEPSY
Why seizure freedom
must remain the goal
In this video, Dr Benbadis discusses the importance of trying different treatment options in patients with epilepsy who remain drug‑resistant—his goal is always to aim for seizure freedom.
Discover once-daily XCOPRI